Allovir Inc
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6,… Read more
Market Cap & Net Worth: Allovir Inc (ALVR)
Allovir Inc (NASDAQ:ALVR) has a market capitalization of $49.48 Million ($49.48 Million) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #29219 globally and #9697 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Allovir Inc's stock price $9.81 by its total outstanding shares 5043360 (5.04 Million).
Allovir Inc Market Cap History: 2020 to 2025
Allovir Inc's market capitalization history from 2020 to 2025. Data shows change from $193.87 Million to $49.48 Million (-18.55% CAGR).
Index Memberships
Allovir Inc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #2422 of 3165 |
Weight: Allovir Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Allovir Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Allovir Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of ALVR by Market Capitalization
Companies near Allovir Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Allovir Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Allovir Inc Historical Marketcap From 2020 to 2025
Between 2020 and today, Allovir Inc's market cap moved from $193.87 Million to $ 49.48 Million, with a yearly change of -18.55%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $49.48 Million | +2235.71% |
| 2024 | $2.12 Million | -38.24% |
| 2023 | $3.43 Million | -86.74% |
| 2022 | $25.87 Million | -60.36% |
| 2021 | $65.26 Million | -66.34% |
| 2020 | $193.87 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Allovir Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $49.48 Million USD |
| MoneyControl | $49.48 Million USD |
| MarketWatch | $49.48 Million USD |
| marketcap.company | $49.48 Million USD |
| Reuters | $49.48 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.